Income Taxes (Tables)

12 Months Ended

Dec. 31, 2023

Income Tax Disclosure [Abstract]

Schedule of Loss before Income Tax Benefit

The sources of loss before income tax benefit are as follows:

(In thousands)	For the year ended December 31,
Current:	2023		2022
Domestic	$	(57,634)	$	(346,468)
Foreign	—		114,149
Total	$	(57,634)	$	(232,319)

Schedule of Components of Income Tax Benefit

Income tax benefit consisted of the following: 

(In thousands)	For the year ended December 31,
Current:	2023		2022
Federal	$	—	$	—
State	(18)		159
Foreign	—		—
Total current expense	(18)		159
Deferred:
Federal	(1,301)		(7,192)
State	101		(1,435)
Foreign	—		(916)
Total deferred benefit	(1,200)		(9,543)
Income tax benefit	$	(1,218)	$	(9,384)

Schedule of Effective Income Tax Rate Reconciliation

Income tax benefit differed from the amount that would be provided by applying the U.S. federal statutory rate due to the following: 

(In thousands)	For the year ended December 31, 2023				For the year ended December 31, 2022
	Amount		Tax Rate		Amount		Tax Rate
Loss before income taxes	$	(57,634)			$	(232,319)
Federal statutory income tax	(12,103)		21.00	%	(48,787)		21.00	%
State income tax, net of federal benefit	110		(0.19)	%	(9,324)		4.01	%
Foreign differential rate	—		—	%	(357)		0.15	%
Goodwill impairment	7,273		(12.62)	%	18,380		(7.91)	%
Transactions costs	3,147		(5.46)	%	187		(0.08)	%
Permanently disallowed interest expense	1,646		(2.86)	%	2,544		(1.10)	%
Valuation allowance	(2,750)		4.77	%	51,670		(22.24)	%
Deconsolidation of subsidiary	(2,412)		4.19	%	(24,766)		10.66	%
Tax gain on sale of Innovations Group	1,760		(3.05)	%	—		—	%
Other	2,111		(3.66)	%	1,069		(0.46)	%
Effective income tax rate	$	(1,218)	2.11	%	$	(9,384)	4.04	%

Schedule of Deferred Tax Assets and Liabilities

Significant components of our deferred taxes are as follows:

(In thousands)	December 31, 2023		December 31, 2022
Deferred Tax Assets
Accrued expenses	$	1,553	$	5,863
Transactions costs	7,453		88
Net operating loss carryforwards	9,112		10,208
Stock compensation	2,048		2,109
Provision for expected credit losses	102		4,097
Disallowed interest expense	4,041		789
Unrealized loss from fair market value adjustment on derivatives	—		14
Investment in Glocal	40,193		40,432
Other	440		865
Total deferred tax assets	64,942		64,465
Deferred Tax Liabilities
Property, plant and equipment	(882)		(1,169)
Intangibles	(5,251)		(5,156)
Convertible debt accretion	(5,420)		(7,670)
Investment in deconsolidated entities	(4,611)		—
Total deferred tax liabilities	(16,164)		(13,995)
Less: valuation allowance	(48,778)		(51,670)
Net deferred tax asset (liability)	$	—	$	(1,200)

Schedule of Activity Related to Unrecognized Tax Benefits

The following table summarizes the activity related to our unrecognized tax benefits:

	For the year ended December 31,
	2023		2022
Beginning balance	$	—	$	1,703
Changes for prior year tax positions	4,519		(1,703)
Ending balance	$	4,519	$	—